openPR Logo
Press release

United States Molecular Cytogenetics Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Business Opportunities

10-08-2025 12:10 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Molecular Cytogenetics Market

Molecular Cytogenetics Market

Market Size and Growth

The Molecular Cytogenetics Market is predicted to reach 9.13% CAGR during the forecast period (2024-2031)

Recent Mergers and acquisitions:

United States: Recent Mergers & Acquisitions

✅ In October 2025, molecular diagnostics firm BillionToOne filed for an Initial Public Offering (IPO) in the United States. The company specializes in precision diagnostics, including non-invasive prenatal screening and liquid biopsies for disease detection. It reported a significant revenue increase in the first half of 2025, reflecting strong investor interest in molecular diagnostics.

✅ In August 2025, a new molecular diagnostics company, Ospri, was formed through the merger of three companies. This strategic consolidation aims to enhance capabilities in molecular diagnostics, including cytogenetic applications, by combining expertise and resources from the founding entities.

✅ In January 2022, Calibre Scientific, a U.S.-based provider of life science reagents and tools, acquired AmpliTech, a France-based company specializing in molecular pathology and cytogenetics. This acquisition expanded Calibre's European portfolio and strengthened its position in the molecular cytogenetics market.

Japan: Recent Mergers & Acquisitions

✅ In August 2025, Japanese company GeneTech acquired BioCytogen, a leading provider of molecular cytogenetics services. This acquisition aims to enhance GeneTech's capabilities in genetic testing and expand its market share in the Asia-Pacific region.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/molecular-cytogenetics-market?sb

Molecular cytogenetics is the study of chromosomes at a molecular level using techniques like fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH). It enables precise detection of genetic abnormalities, structural variations, and chromosomal disorders, supporting diagnostics, personalized medicine, and genetic research.

Key Players:

=> Applied Spectral Imaging, Oxford Gene Technology, Bio-Rad Laboratories, Illumina, Inc., PerkinElmer, Inc., Agilent Technologies, Abbott Laboratories, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., MetaSystems, and Quest Diagnostics Incorporated.

Growth Forecast Projected:

The Global Molecular Cytogenetics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Molecular Cytogenetics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=molecular-cytogenetics-market

Key Segments:

➥ By Product: Kits & Reagents, Instruments, Consumables, Software & Services
➥ By Technique: Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Karyotyping, Others
➥ By Application: Genetic Disorders, Oncology, Targeted Drug Therapy, Others
➥ By End User: Clinical & Research Laboratories, Academic Research Institutes, Hospitals & Pathology Laboratories, Pharmaceutical & Biotechnology Companies, Others

Regional Analysis for Molecular Cytogenetics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Molecular Cytogenetics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Molecular Cytogenetics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/molecular-cytogenetics-market?sb

FAQ

Q: What is the growth rate of the Molecular Cytogenetics Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 9.13% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Molecular Cytogenetics Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Business Opportunities here

News-ID: 4213617 • Views:

More Releases from DataM intelligence 4 Market Research LLP

USA Fintech as a Service Market Projected to Reach $1.06 Trillion by 2032 | Fueled by Digital Transformation & API Innovation
USA Fintech as a Service Market Projected to Reach $1.06 Trillion by 2032 | Fuel …
DataM Intelligence announces its comprehensive report, "Fintech as a Service Market: Size, Share, Trends & Forecast 2025-2032." According to the analysis, the Fintech as a Service (FaaS) Market reached USD 321.04 billion in 2024 and is projected to grow at a CAGR of 16.10%, achieving USD 1,059.78 billion by 2032. In 2025, the market is witnessing robust expansion as financial institutions and enterprises increasingly embed financial capabilities such as payments,
AI in Healthcare Market to Reach USD 305.96 Billion by 2033, Growing at 30.1% CAGR | DataM Intelligence
AI in Healthcare Market to Reach USD 305.96 Billion by 2033, Growing at 30.1% CA …
The global AI in Healthcare market is experiencing unprecedented growth, driven by the convergence of big data, advanced computing power, and the urgent need for improved healthcare efficiency and outcomes. Artificial Intelligence is revolutionizing healthcare through applications in medical imaging, drug discovery, personalized medicine, and patient management. These technologies serve as crucial tools for healthcare providers, enabling more accurate diagnoses, optimized treatment plans, and enhanced operational efficiency while reducing costs
Low-Grade Glioma Market to Reach USD 4.7 Billion by 2033, Fueled by Advances in Targeted Therapies and Molecular Diagnostics, Reports DataM Intelligence
Low-Grade Glioma Market to Reach USD 4.7 Billion by 2033, Fueled by Advances in …
The global Low-Grade Glioma (LGG) market is witnessing significant growth, driven by advancements in diagnostic technologies and the development of targeted therapeutic agents. Low-grade gliomas are primary brain tumors characterized by slower growth rates, affecting both pediatric and adult populations. The market encompasses a range of treatment modalities including surgical interventions, radiation therapy, and novel pharmaceutical approaches, with increasing focus on molecular profiling and personalized treatment strategies to improve patient
United States Multiple Sclerosis Therapeutics Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Multiple Sclerosis Therapeutics Market 2025 | Growth Drivers, Key …
Market Size and Growth The Global Multiple Sclerosis Therapeutics Market reached US$ 22.84 billion in 2023 and is expected to reach US$ 26.57 billion by 2031, growing at a CAGR of 1.95% during the forecast period 2024-2031. Key Development: United States: Recent Industry Developments ✅ In October 2025, Harness Therapeutics launched its MISBA® Duo platform and entered into a research collaboration with Ono Venture Investment. This initiative aims to advance the development of novel

All 5 Releases


More Releases for Molecular

Molecular Breeding Market Report 2024 - Molecular Breeding Market Size, Share An …
"The Business Research Company recently released a comprehensive report on the Global Molecular Breeding Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The molecular breeding market size
Molecular Quality Controls: Ensuring Precision and Reliability in Molecular Diag …
Introduction Molecular quality controls (MQCs) play a critical role in molecular diagnostics, helping laboratories and healthcare providers ensure the accuracy, reliability, and consistency of diagnostic tests. These quality controls are essential in detecting and monitoring infectious diseases, genetic disorders, cancer biomarkers, and other molecular targets. By providing standards that verify the performance of diagnostic assays, MQCs help reduce errors, minimize false results, and maintain compliance with regulatory standards. As the demand
Molecular Diagnostic Platform Market Advancing Molecular Diagnostics with Innova …
Global Molecular Diagnostic Platform Market Overview: The Molecular Diagnostic Platform market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Molecular Diagnostic Platform market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth
Molecular Modeling Market - Visualizing the unseen: Molecular modeling for grou …
Newark, New Castle, USA: The "Molecular Modeling Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Molecular Modeling Market: https://www.growthplusreports.com/report/molecular-modeling-market/8615 This latest report researches the industry structure, sales, revenue,
Molecular Diagnostics Market - Empowering healthcare through molecular precision …
Newark, New Castle, USA: The "Molecular Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Molecular Diagnostics Market: https://www.growthplusreports.com/report/molecular-diagnostics-market/7674 This latest report researches the industry structure, sales, revenue,
Molecular Imaging Device Market scenario for 2022 | Trivitron Healthcare, Molecu …
The Molecular Imaging Device market report anticipate the market growth and recent developments in market competition which helps players to strategies and analysis the position in Molecular Imaging Device market. It also indicates the risk factors, advancements, market drivers, revenue, business scenario, growth potential, market scope, new trends, and historical data of Molecular Imaging Device market. With this futuristic approach researchers also provides a close study of market forecast, overview